Universität zu Köln

2021

Dold, L., Zimmer, L., Schwarze-Zander, C., Boesecke, C., Mohr, R., Wasmuth, J. -C., Ommer, K., Gathof, B., Kraemer, B., Nattermann, J., Strassburg, C. P., Rockstroh, J. K., Spengler, U. and Langhans, B. (2021). TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients. J. Mol. Med., 99 (1). S. 147 - 159. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1440

2020

Franklin, C., Wetter, A., Baba, H. A., Cosgarea, I., Mauch, C., Livingstone, E., Zimmer, L., Schadendorf, D. and Ugurel, S. (2020). The diagnostic Significance of CT-controlled Puncture in Skin Cancer Patients. J. Dtsch. Dermatol. Ges., 18. S. 27 - 28. HOBOKEN: WILEY. ISSN 1610-0387

Kramer, R., Mentzer, D., Erdmann, M., Knauss, S., Broeckelmann, P. J., Hassel, J. C., Ugurel, S., Pavel, M., Nickel, F. T., Landendinger, M., Fuchs, F., Meidenbauer, N., Jefremow, A., Manger, B., Gutzmer, R., Loquai, C., Kaehler, K., Zimmer, L., Berking, C., Keller-Stanislawski, B. and Heinzerling, L. (2020). SERIO - Side Effect Registry Immuno-Oncology Side Effect Registry for rare, severe and complex Side Effects of Immunotherapy. J. Dtsch. Dermatol. Ges., 18. S. 14 - 16. HOBOKEN: WILEY. ISSN 1610-0387

Livingstone, E., Zaremba, A., Horn, S., Ugurel, S., Casalini, B., Schlaak, M., Hassel, J. C., Herbst, R., Utikal, J. S., Weide, B., Gutzmer, R., Meier, F., Koelsche, C., Hadaschik, E., Sucker, A., Reis, H., Merkelbach-Bruse, S., Siewert, M., Sahm, F., von Deimling, A., Cosgarea, I., Zimmer, L., Schadendorf, D., Schilling, B. and Griewank, K. G. (2020). GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma. Br. J. Dermatol., 183 (5). S. 928 - 940. HOBOKEN: WILEY. ISSN 1365-2133

Zaremba, A., Martaki, A., Salzmann, M., Baroudjian, B., Sachse, M. M., Gesierich, A., Reinhardt, L., Meier, F., Hassel, J. C., Ugurel, S., Roesch, A., Schadendorf, D., Livingstone, E., Broeckelmann, P., Kramer, R., Heinzerling, L. and Zimmer, L. (2020). Agranulocytosis with Immune Checkpoint-Blockade - a retrospective, multicenter Evaluation. J. Dtsch. Dermatol. Ges., 18. S. 15 - 17. HOBOKEN: WILEY. ISSN 1610-0387

2017

Cosgarea, I, Zimmer, L., Weide, B., Gutzmer, R., Heinzerling, L., Weishaupt, C., Pfoehler, C., Gesierich, A., Herbst, R., Kaehler, K., Schlaak, M., Loquai, C., Utikal, J., Kaatz, M., Berking, C., Kreuter, A., Ulrich, J., Mohr, P., Dippel, E., Livingstone, E., Weichenthal, M., Schadendorf, D. and Ugurel, S. (2017). Interleukin-2 and Checkpoint Inhibition as a successful Therapy Sequence for metastatic Melanoma: Case Report and retrospective Analysis in 52 Patients. J. Dtsch. Dermatol. Ges., 15. S. 16 - 18. HOBOKEN: WILEY. ISSN 1610-0387

2016

Hassel, J., Forschner, A., Bluhm, L., Heinzerling, L., Zimmer, L., Utikal, J., Kaehler, K., Schlaak, M., Loquai, C., Gutzmer, R., Kieker, F., Berking, C., Bender, A., Schneider, L., Enk, A., Garbe, C., Weichenthal, M., Schadendorf, D., Hauschild, A. and Mohr, P. (2016). Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP). J. Dtsch. Dermatol. Ges., 14. S. 9 - 10. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387

2015

Stark-Lorenzen, P., Berking, C., Garbe, C., Gesierich, A., Huber, M. A., Pinter, A., Zimmer, L., Schlaak, M., Ulrich, J., Rech, S. and Gutzmer, R. (2015). MelaniE (Melanoma in Expert Centers)- Retrospective Data Collection for the Evaluation of the Implementation of the S3-Guideline in the oncological Clinical Practice. J. Dtsch. Dermatol. Ges., 13. S. 15 - 17. HOBOKEN: WILEY-BLACKWELL. ISSN 1610-0387